MSN Labs Europe Limited Pharmadox Healthcare Ltd.
PolandAll drugs from this manufacturer
-
The medicine is used to treat prostate cancer when the disease has been found to progress after the use of another chemotherapy.
Dosage form: solution for infusion, concentrate and solvent
Active substance Dosage cabazitaxel 60 mg ATC: L01CD04
-
The medicine is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia and other types of anemia who have excess iron due to frequent blood transfusions or increased iron absorption from food.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 90 mg ATC: V03AC03
-
The medicine is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia who have chronic iron overload due to frequent blood transfusions, as well as for patients with other types of anemia or transfusion-independent thalassemia syndromes.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 180 mg ATC: V03AC03
-
The medicine is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia who have chronic iron overload due to frequent blood transfusions, and for patients with other types of anemia or transfusion-independent thalassemia syndromes.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 360 mg ATC: V03AC03
-
The medicine is used in adults to treat relapsing forms of multiple sclerosis (MS), particularly in individuals who have not responded to other treatments or in whom the disease is progressing rapidly and severely. It may also be used in children aged 10 years and older. It helps to reduce the number of relapses and slow the progression of disability.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0.5 mg ATC: L04AA27
-
The medicine is used to facilitate the collection of hematopoietic stem cells for subsequent storage and transplantation. It is intended for adults with lymphoma or multiple myeloma and for children (from 1 to 18 years of age) with lymphoma or solid tumors.
Dosage form: solution for injection
Active substance Dosage plerixafor 20 mg/ml ATC: L03AX16
-
Qydaxer is used in adults to prevent the formation of blood clots in hardened arteries. This helps to reduce the risk of stroke, heart attack, or death in people with atherosclerosis, peripheral artery disease, unstable angina, or after cardiovascular events.
Dosage form: tablets, film-coated
Active substance Dosage clopidogrel 75 mg ATC: B01AC04
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Dosage form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors.
Dosage form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Dosage form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Dosage form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
-
It is used in adults as well as in children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis. It helps protect the nervous system by regulating the activity of the immune system.
Dosage form: tablets, film-coated
Active substance Dosage teriflunomide 14 mg ATC: L04AA31